AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Quoin Pharmaceuticals, Ltd. Director's Dealing 2025

Sep 8, 2025

35443_dirs_2025-09-08_588f9930-1d11-4e45-b2fb-cd3e777675a9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Quoin Pharmaceuticals, Ltd. (QNRX)
CIK: 0001671502
Period of Report: 2025-08-18

Reporting Person: Lawlor Sally Bridget (CHIEF FINANCIAL OFFICER)

Holdings (Non-Derivative)

Security	Shares	Ownership
ADS	440	Direct

Footnotes

F1: The number of securities are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.